e lb in approximately 9.10 months after IND Strategic objective • Following positive Phase lb data, seek licensing partner for development through Phases 2 & 3 or sell asset 31 EFTA00506100 Epiphany Biosciences Corporate Highlights = Milestones, Team, & Value Proposition 31 ___ IIIM 32 EFTA0050610